|
|
|
Volumn 61, Issue 3, 2000, Pages 161-163
|
|
Appropriate clinical management of women taking valproate
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHOLESTEROL;
HIGH DENSITY LIPOPROTEIN;
INSULIN;
LAMOTRIGINE;
TESTOSTERONE;
TRIACYLGLYCEROL;
VALPROATE SEMISODIUM;
VALPROIC ACID;
BODY MASS;
CARDIOVASCULAR RISK;
EPILEPSY;
FEMALE;
HUMAN;
HYPERANDROGENISM;
INSULIN RESISTANCE;
MENSTRUATION DISORDER;
MENTAL DISEASE;
NOTE;
OVARY POLYCYSTIC DISEASE;
PATIENT COUNSELING;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RISK BENEFIT ANALYSIS;
WEIGHT GAIN;
WELLBEING;
ADULT;
AGE FACTORS;
ANTICONVULSANTS;
BODY WEIGHT;
EPILEPSY;
FEMALE;
HUMANS;
HYPERANDROGENISM;
INSULIN RESISTANCE;
MENSTRUATION DISTURBANCES;
POLYCYSTIC OVARY SYNDROME;
PRACTICE GUIDELINES;
RISK FACTORS;
SEX FACTORS;
VALPROIC ACID;
|
|
EID: 0033994321
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (7)
|
|
References (12)
|
